Business Wire

Ankyra Therapeutics Presents First Preclinical Data on ANK-203, a Novel CD137-Anchored Immunotherapy Candidate, in Oral Session at AACR IO

ANK-203 is a first-in-class anchored immunotherapy designed to unlock the full therapeutic potential of monoclonal antibody CD137 through localized delivery and retention In preclinical studies, ...
Business Wire

Ankyra Therapeutics Announces First Visceral Tumor Patient Dosed in Phase 1 ANCHOR Clinical Trial of ANK-101, an Anchored Interleukin-12 (IL-12)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored therapy to treat cancer, today announced the first patient dosed in a visceral tumor ...
IGN

Ank Parako

ISB Reports are tablets containing profiles made by the Empire regarding the various unscrupulous individuals across the game (or just people they don't like). Finding these will help you learn more ...
Seeking Alpha

ANK:CA Angkor Resources Corp.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...